Strata Skin Sciences Inc.

Strata Skin Sciences Inc., a for-profit medical technology company headquartered in Horsham, Pennsylvania, manufactures and maintains FDA-approved dermatological excimer laser systems for federal healthcare providers, operating exclusively as a prime contractor on small-value purchase orders with no subcontract footprint. The vendor competes in full-and-open procurements; recent awards carry no set-aside designations, though one 2022 award carried a Total Small Business set-aside marking.

Strata's product portfolio centers on 308-nanometer monochromatic ultraviolet B excimer laser systems (XCIMER and XTRAC models) used to treat psoriasis, eczema, vitiligo, cutaneous skin lymphoma, and other dermatological conditions. Representative recent work includes a $89,900 sole-source purchase order awarded by the Department of Veterans Affairs Veterans Integrated Service Network 21 on August 18, 2026, for a Strata XCIMER laser system following VA market research confirming Strata as the sole provider of FDA-approved 308-nanometer excimer laser systems with no authorized distributors; a $60,000 firm-fixed-price maintenance agreement with VA VISN 10 awarded March 13, 2024, for XTRAC excimer laser system maintenance at VA medical centers in the Cleveland, Ohio area; and a $69,900 excimer laser system delivery to VA VISN 22 awarded September 13, 2023. The vendor also delivers laser repair and maintenance services at VA facilities.

Customer concentration sits heavily with the Department of Veterans Affairs. The top five customers by award count and combined potential value account for 71% and 73% of awards respectively, with VA Veterans Integrated Service Network 10 leading at seven awards and $295 thousand combined potential value, followed by VA VISN 8 with seven awards and $168 thousand, and the Department of the Air Force with six awards. Air Force Air Mobility Command places the second-highest dollar value at three awards worth $233 thousand. The vendor serves thirteen distinct federal customer agencies across the portfolio. Recent activity shows one award in 2024 and one in 2026, following three-award years in 2021 through 2023; combined potential value across all thirty-five prime awards sits at $1.3 million, though combined dollars obligated exceed that at $1.9 million. Work is performed at Horsham, Pennsylvania and at subordinate VA medical centers nationwide. The vendor holds no parent vehicles, GWACs, or BPAs; all awards are discrete purchase orders issued directly by VA VISNs and Air Force commands.